Skip to content

Clinical trials

Active, not recruiting Lung Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Active, not recruiting Country / region: Netherlands Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20192
20201
20212
20224
20231
20246

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Maastricht Radiation Oncology2
Novartis Pharmaceuticals2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Actuate Therapeutics Inc.1
Amgen1
Boehringer Ingelheim1
Creo Medical Limited1
Genmab1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms17
Carcinoma, Non-Small-Cell Lung6
Neoplasm Metastasis3
Colorectal Neoplasms2
Neoplasms2
Bites and Stings1
Bone Neoplasms1
Breast Neoplasms1
Carcinoma1
Glioma1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.